Proto Script Pharmaceutical (Proto Script Pharmaceutical) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2017)

View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Proto Script Pharmaceutical's long-term debt to total assests ratio for the quarter that ended in Sep. 2017 was 0.00.

Proto Script Pharmaceutical's long-term debt to total assets ratio stayed the same from Sep. 2016 (0.00) to Sep. 2017 (0.00).

Proto Script Pharmaceutical LT-Debt-to-Total-Asset Historical Data

The historical data trend for Proto Script Pharmaceutical's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical LT-Debt-to-Total-Asset Chart

Proto Script Pharmaceutical Annual Data

Trend

May12

May13

May14

May15

May16

LT-Debt-to-Total-Asset

Proto Script Pharmaceutical Quarterly Data
	Nov12	Feb13	May13	Aug13	Nov13	Feb14	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Sep16	Dec16	Mar17	Jun17	Sep17
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Proto Script Pharmaceutical LT-Debt-to-Total-Asset Calculation

Proto Script Pharmaceutical's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in May. 2016 is calculated as

LT Debt to Total Assets (A: May. 2016 )	=	Long-Term Debt & Capital Lease Obligation (A: May. 2016 )	/	Total Assets (A: May. 2016 )
	=	0	/	0.012
	=

Proto Script Pharmaceutical's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2017 is calculated as

LT Debt to Total Assets (Q: Sep. 2017 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2017 )	/	Total Assets (Q: Sep. 2017 )
	=	0	/	0.235
	=	0.00

Proto Script Pharmaceutical (OTCPK:PSCR) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Proto Script Pharmaceutical LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730

Website

http://www.psphomecare.com

Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines